Plain-English translation of NCT06082531 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether platelet-rich plasma (PRP)—a concentrated form of your own blood platelets—can help repair knee osteoarthritis and injuries to the cartilage and meniscus (cushioning tissue) around the knee joint. Researchers will give some patients injections of this treatment at specific time points and measure whether it reduces pain and improves healing.
Knee arthritis and cartilage injuries are common and difficult to treat with standard approaches. This treatment aims to harness your body's natural healing abilities to repair damaged joint tissue and potentially slow or reverse the damage caused by osteoarthritis.
You likely qualify if…
You likely don't qualify if…
You will receive PRP injections into your knee at two time points after an initial evaluation: one at 6 weeks and another at 3 months. Between these visits, you'll likely have follow-up appointments to monitor your pain, function, and healing with physical exams and imaging. The entire study span covers several months of treatment and follow-up care at Xijing Hospital.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
China
Sponsor
Xijing Hospital
Enrollment target
~300 participants
Started
September 2023
Primary completion
December 2026
Age range
20 Years – 60 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yanyan Jia
Xijing Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.